|Bid||48.00 x 1100|
|Ask||51.69 x 1100|
|Day's Range||50.04 - 50.81|
|52 Week Range||33.00 - 65.90|
|Beta (5Y Monthly)||0.96|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||72.67|
Subscribe to Yahoo Finance Plus to view Fair Value for PRTCLearn more
BOSTON, October 14, 2021--PureTech Health announced that its Founded Entity, Vedanta Biosciences, has appointed Dr. Simona Levi as Chief Legal Officer and Corporate Secretary.
BOSTON, October 05, 2021--PureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-Being
BOSTON, September 29, 2021--PureTech Founded Entity Akili announces topline results from Shionogi Phase 2 study of SDT-001 (Japanese version of AKL-T01).